retatrutide type 2 diabetes phase 2 results 2024 2025 ๐ A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new 3 trial shows. is part of an emerging generation New Kind of Diabetes Drug
Description
K., Fraser, I
Both medications have shown strong results for weight management
Once approved, switching will likely be common
Wool carefully screens patients for contraindications including personal or family history of medullary thyroid cancer, pancreatitis, or severe gastrointestinal conditions
Brief room-temperature exposure during normal handling is usually unavoidable
